(Total Views: 108)
Posted On: 07/02/2019 10:25:42 AM
Post# of 124729
$CALA News Article - Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizer's CDK4/6 Inhibitor Palbociclib https://marketwirenews.com/news-releases/cali...46416.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
